Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN108822170B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108822170B reveals novel anthraquinone imidazole riboside analogues with improved solubility and anticancer activity, offering scalable synthetic routes for pharmaceutical intermediates.